March 13, 2017 / TheNewswire / Vancouver, British Columbia – AREV Nutrition Sciences Inc. (the “Company” or “AREV”) (CSE: ARV) is pleased to announce that it has arranged a private placement (the “Private Placement”) of units (each, a “Unit”), at a price of $0.25 per Unit, for gross proceeds of up to $2,000,000.

 

Each Unit is comprised of one common share (the “Shares”) of the Company and one common share purchase warrant (the “Warrants”). Subject to adjustment in certain events, each Warrant entitles the holder thereof to purchase one additional common share (the “Warrant Shares”) of the Company at an exercise price of $0.40 per Warrant Share at any time on or before 5:00 P.M. (Vancouver time) on the date that is 12 months from the date of issuance of the Warrants. The company has the option to call the warrant if the stock price trades over .70 per share for 10 consecutive days.

 

AREV is pleased to announce the launch of its web site www.arevnutrition.com and the launch of its innovation COCO-MULSION product line at Natural Products Expo West in Anaheim, California where the company commenced its action plan to become the leader of nutraceutical products that are a hybrid of vitamin supplements and functional food, providing good daily nutrition for health conscious consumers.

 

Mr. Stephane Maher commented, “The response to our innovative products has been extremely well received by representatives from companies based in the US, Middle East, Europe and Asia.” He went on to say, “ The real work starts now in the follow up and signing distribution and private label licensing agreements.“

   

For further information, contact Stephane Maher at 604.868.5013.

 

On behalf of the Board,

 

AREV Nutrition Sciences Inc.

 

“Stephane Maher”

 

CEO and Director

 

About AREV Nutrition Sciences Inc.

AREV produces and delivers functional ingredients from its world-class extraction system. AREV is revolutionizing the current delivery method of coconut oil, whey protein and nutrients through emulsification. These premium ingredients and products are targeted for the natural health, medical, functional food, nutraceutical, sport nutrition and bioceutical markets.  AREV is also working with Pharmacy and Dispensary operators with an innovative emulsified base formula to disperse Cannabis oil extracts.

 

The Canadian Securities Exchange has not in any way passed upon the merits of the proposed transaction and have neither approved nor disapproved the contents of this press release. Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in policies of the CSE) accepts responsibility for the adequacy or accuracy of this release. This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under applicable securities laws.